File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis?

TitleIdentifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis?
Authors
Issue Date2022
Citation
Journal of Clinical Oncology, 2022, v. 40 n. 11, p. 1135-1138 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/313778
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorNg, WT-
dc.contributor.authorChua, MLK-
dc.contributor.authorLee, WMA-
dc.date.accessioned2022-07-05T05:05:32Z-
dc.date.available2022-07-05T05:05:32Z-
dc.date.issued2022-
dc.identifier.citationJournal of Clinical Oncology, 2022, v. 40 n. 11, p. 1135-1138-
dc.identifier.urihttp://hdl.handle.net/10722/313778-
dc.languageeng-
dc.relation.ispartofJournal of Clinical Oncology-
dc.titleIdentifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis?-
dc.typeArticle-
dc.identifier.emailNg, WT: ngwt1@hkucc.hku.hk-
dc.identifier.emailLee, WMA: awmlee@hkucc.hku.hk-
dc.identifier.authorityNg, WT=rp02671-
dc.identifier.authorityLee, WMA=rp02056-
dc.identifier.doi10.1200/JCO.22.00099-
dc.identifier.hkuros333959-
dc.identifier.volume40-
dc.identifier.issue11-
dc.identifier.spage1135-
dc.identifier.epage1138-
dc.identifier.isiWOS:000801055800001-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats